Bhavya S Doshi

8PUBLICATIONS
6CO-AUTHORS
Haematological tumoursMedical devicesGene and molecular therapyHaematologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 01, 2024
Coagulation factor VIII: biological basis of emerging hemophilia A therapies.

Benjamin J Samelson-Jones, Bhavya S Doshi, Lindsey A George

|Jul 10, 2024
Enhanced procoagulant activity of select hemophilia B causing factor IX variants with emicizumab.

Kyumin Lee, Julia Q Chau, Yani B Suber

|May 30, 2024
RNAing toward a new therapy for hemophilia.

Bhavya S Doshi, Robert F Sidonio

|May 20, 2022
Acquired Hemophilia A: Current Guidance and Experience from Clinical Practice.

Allyson M Pishko, Bhavya S Doshi

|Apr 18, 2021
Recurrence of a high-titre factor VIII inhibitor in a haemophilia A patient on emicizumab prophylaxis.

Bhavya S Doshi, Char M Witmer

|Jan 28, 2020
Combined anti-CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors.

Bhavya S Doshi, Leslie J Raffini, Lindsey A George

Pageof 2

Frequent Collaborators

3 joint publications

Lindsey A George

2 joint publications

Benjamin J Samelson-Jones

1 joint publications

Alan R Cohen

1 joint publications

Robert F Sidonio